$NVCR news
The latest NVCR stock news: headlines, filings, AI summaries and sentiment for $NVCR, updated around the clock.
- FDA Issues Not Approvable Letter for NovoCure's Optune Mya
- NovoCure Ltd - 8-K Filing
- NovoCure Reports Record Q3 2026 Revenue and Raises Full-Year Guidance
- NovoCure Shares Decline Despite Q3 Earnings Beat and Upward Revenue Guidance
- NovoCure Reports Record Q3 2026 Revenue and First Positive Adjusted EBITDA in Four Years
- NovoCure Reports Q3 Earnings Beat and Updates FY26 Financial Outlook
- NovoCure Ltd - 10-Q Filing
- NovoCure Ltd - 8-K Filing
- NovoCure Ltd - 8-K Filing
- NovoCure Ltd - 8-K Filing
- NovoCure Ltd - 8-K Filing
- Pomerantz Law Firm Investigates NovoCure Following Disappointing Trial Results
- Investor Alert: Pomerantz Law Firm Investigates NovoCure Limited for Potential Securities Fraud
- Broadcom Drags on Nasdaq as Semiconductor Sell-Off Hits Market
- Soleus Capital Adds $63M to Vericel Stake Amid Revenue Growth
- NovoCure (NVCR) Q1 2026 Earnings Call Summary
- Medical Stocks Lead The Day; With One About To Break Out
- NovoCure Reports Q1 2026 Earnings, Highlights Optune PAX Launch and Financial Performance